ALERE INC.·4

Oct 3, 5:32 PM ET

Ginsburg Geoffrey S 4

4 · ALERE INC. · Filed Oct 3, 2017

Insider Transaction Report

Form 4Exit
Period: 2017-10-03
Transactions
  • Disposition to Issuer

    Common Stock

    [F1]
    2017-10-035,5300 total
Footnotes (1)
  • [F1]Pursuant to that certain Agreement and Plan of Merger, dated as of January 30, 2016, as amended on April 13, 2017 (the "Merger Agreement"), between Alere Inc. (the "Company") and Abbott Laboratories, at the Effective Time (as defined in the Merger Agreement) (the "Effective Time"), each of these shares of the Company's common stock (the "Common Stock") was converted into the right to receive $51.00 (the "Merger Consideration").
Signature
/s/ Doug Barry, Attorney-in-Fact|2017-10-03

Documents

1 file
  • 4
    es1701006_4-ginsburg.xmlPrimary

    OWNERSHIP DOCUMENT